Back to Directory
Last Updated: 09/05/2026
Blue Beagle Bio
London
Founded 2022
Novel gene synthesis technology for faster, lower-cost DNA production
Blue Beagle Bio is an early-stage biotechnology company developing a novel gene synthesis method aimed at delivering faster turnaround times and lower costs compared to existing commercial services.
The company targets researchers in academia, SMEs, and the pharmaceutical industry, where access to accurate synthetic DNA remains a limiting factor in biological research and development workflows.
Blue Beagle Bio was establishing its first commercial offering in 2026.
Company Notes
Member of